Your funds, side by side
The lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- Virtus Biotech Clinical Trials Etf ETFis Series Trust I · 124 lines · as of Apr 30, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | Virtus Biotech Clinical Trials Etf |
|---|---|
| Erasca Inc | 2.19 % |
| Enliven Therapeutics Inc | 1.81 % |
| Tango Therapeutics Inc | 1.71 % |
| Oruka Therapeutics Inc | 1.68 % |
| Spyre Therapeutics Inc | 1.64 % |
| Alumis Inc | 1.59 % |
| Dianthus Therapeutics Inc | 1.54 % |
| Kodiak Sciences Inc | 1.35 % |
| Revolution Medicines Inc | 1.35 % |
| Corvus Pharmaceuticals Inc | 1.34 % |
| Rezolute Inc | 1.31 % |
| Definium Therapeutics Inc | 1.29 % |
| CG oncology Inc | 1.21 % |
| JADE BIOSCIENCES INC | 1.20 % |
| Inhibrx Biosciences Inc | 1.20 % |
| Relay Therapeutics Inc | 1.19 % |
| GH RESEARCH PLC | 1.16 % |
| Nektar Therapeutics | 1.15 % |
| Tyra Biosciences Inc | 1.14 % |
| Vir Biotechnology Inc | 1.13 % |
| Intellia Therapeutics Inc | 1.10 % |
| CENTESSA PHARMACEUTICALS PLC | 1.10 % |
| AnaptysBio Inc | 1.08 % |
| Omeros Corp | 1.06 % |
| Tectonic Therapeutic Inc | 1.05 % |
| Allogene Therapeutics Inc | 1.04 % |
| Compass Pathways plc | 0.99 % |
| Edgewise Therapeutics Inc | 0.97 % |
| Palvella Therapeutics Inc | 0.96 % |
| Capricor Therapeutics Inc | 0.95 % |
1 funds, 124 lines read.